Sept 21 (Reuters) – Drug developer Iambic Therapeutics, backed by chip giant Nvidia and Qatar's sovereign wealth fund, filed for a US initial public offering on Monday, bolstering a busy slate of
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
* Alibaba plans model with 5 trillion to 10 trillion parameters * Unveils New Zhenwu…
VIDEO SHOWS: HIGHLIGHTS OF THE MLB GAME BETWEEN THE DETROIT TIGERS AND WASHINGTON NATIONALS RESENDING…
New Delhi [India], September 22: Park Medi World Limited (NSE: PARKHOSPS; BSE: 544645): Park Group…
By Elisa Anzolin and Helen Reid MILAN/LONDON, Sept 22 (Reuters) - Glitzy runway shows by…
BEIJING, Sept 22 (Reuters) - Alibaba Group plans to train a new artificial intelligence model…
JOHANNESBURG, Sept 22 (Reuters) - The following scheduled economic events, equity and currency market moves…